Abstract #3834
Molecular MRI and DCE-US to evaluate anti-angiogenic therapies in kidney tumor xenografts
Ludovic de Rochefort 1 , Ingrid Leguerney 1 , Marie Poirier-Quinot 1 , Sandra Robin 1 , Xavier Violas 2 , Rose-Marie Dubuisson 1 , Stphanie Pitre-Champagnat 1 , Luc Darrasse 1 , Philippe Robert 2 , and Nathalie Lassau 1
1
IR4M, Univ. Paris-Sud, CNRS, UMR 8081, Orsay,
France,
2
Experimental
Imaging, MRI unit, Research Division, Guerbet,
Aulnay-sous-bois, France
A multimodal molecular MRI and DCE-US protocol was
applied in kidney tumor xenograft in mice to follow up
the response to anti-angiogenic treatments. Imaging was
performed at D0 and D3 after monoclonal anti-body,
tyrosine kinase inhibitor and m-Tor inhibitor
administration. Tumor growth, perfusion (US), diffusion,
first pass enhancement (1 min) and late enhancement (1
hour) of a targeted 3 contrast agent (MRI) were
quantified. Tumor growth was reduced with treatments.
Differences were observed in apparent diffusion
coefficient, targeted contrast agent clearance and
fixation in the different groups after treatment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
